| Drug Type CAR-T | 
| Synonyms CD19-CAR-mbIL15-DNT Cells(Ruishun Biotech) | 
| Target- | 
| Action- | 
| Mechanism- | 
| Therapeutic Areas | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| High grade B-cell lymphoma | Phase 1 | - | 01 Apr 2025 | |
| Mediastinal large B-cell lymphoma | Phase 1 | - | 01 Apr 2025 | |
| Philadelphia positive acute lymphocytic leukaemia | Phase 1 | - | 01 Apr 2025 | |
| Pre B-cell acute lymphoblastic leukemia | Phase 1 | - | 01 Apr 2025 | 





